What is Wolfe Research's price target for RUN?

Wolfe Research's latest stated price target for Sunrun Inc. (RUN) is $43, from its action on Feb 18, 2022.

What is Wolfe Research's rating on RUN?

Wolfe Research rates RUN Peer Perform, a neutral rating, as of Oct 20, 2022.

When did Wolfe Research last change its view on RUN?

On Oct 20, 2022, Wolfe Research downgrades to Peer Perform from Outperform.

Wolfe Research RUN price target and rating history

Wolfe Research rates Sunrun Inc. (RUN) Peer Perform with a $43 price target, as of its latest action on Oct 20, 2022. It has published 3 rating actions on RUN since September 2021, including 0 upgrades and 1 downgrade.

Current rating: Peer Perform
Price target: $43
Median target, all firms: Too few
Actions on RUN: 3

Wolfe Research price target on RUN

Wolfe Research price target on RUN, each point a stated target, September 2021 to February 2022.

Every Wolfe Research rating on RUN

Oct 20, 2022
DowngradeWolfe Research downgrades to Peer Perform from Outperform
Feb 18, 2022
ReiterateWolfe Research cuts its price target to $43 from $50, keeps Outperform
Sep 1, 2021
InitiateWolfe Research starts coverage at Outperform, price target $62

How other firms rate RUN

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
TD Cowen	Buy	$16	Aug 6, 2026
Raymond James	Mkt Perform		Jan 13, 2026
Guggenheim	Buy	$27	Nov 10, 2025

Questions about Wolfe Research and RUN

What is Wolfe Research's price target for RUN?: Wolfe Research's latest stated price target for Sunrun Inc. (RUN) is $43, from its action on Feb 18, 2022.
What is Wolfe Research's rating on RUN?: Wolfe Research rates RUN Peer Perform, a neutral rating, as of Oct 20, 2022.
When did Wolfe Research last change its view on RUN?: On Oct 20, 2022, Wolfe Research downgrades to Peer Perform from Outperform.

More RUN rating histories

All Wolfe Research ratings RUN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.